Cargando…

Protein kinase inhibitors as sensitizing agents for chemotherapy /

Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Chen, Zhe-Sheng (Jason) (Editor ), Yang, Dong-Hua (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, United Kingdom : Academic Press, an imprint of Elsevier, [2019]
Colección:Cancer sensitizing agents for chemotherapy ; v. 4.
Temas:
Acceso en línea:Texto completo
Texto completo
Descripción
Sumario:Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.
Descripción Física:1 online resource
Bibliografía:Includes bibliographical references and index.
ISBN:9780128127384
0128127384
9780128164358
0128164352